FTT 0.00% 0.5¢ factor therapeutics limited

...still, it is inconsistent to blame a particular trial result...

  1. 477 Posts.
    lightbulb Created with Sketch. 60
    ...still, it is inconsistent to blame a particular trial result (failure) on the standard of care and at the same time shut down the platform in other areas of opportunity that do not have the same problem of advancement in standard of care. 
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.